CLINICAL_TRIALS
research
· 2016-03-16
Clinical Trial Update: Resection+Highly Purified CTL Versus Resection Alone for HCC [Phase 3]
Summary
Phase 3 trial compares resection plus Highly Purified Cytotoxic T Lymphocytes (CTLs) versus resection alone for hepatocellular carcinoma. The current status is …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN